1-5 of 5
Martijn R. Schaafsma
Close
Sort by
Journal Articles

Validation Of a Multi-Diagnostic Approach Including Flow Cytometry To Identify Specific Risk Categories Within Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

Eline M.P. Cremers, MD, Theresia M. Westers, PhD, Canan Alhan, MD, Claudia Cali, Heleen A. Visser-Wisselaar, PhD, Dana A Chitu, PhD, Marian J.P.L. Stevens-Kroef, PhD, Pedro Silva Coelho, MD, Edo Vellenga, MD, PhD, Saskia K. Klein, MD PhD, Pierre W. Wijermans, MD, PhD, Georgine E. de Greef, MD, PhD, Martijn R. Schaafsma, MD, PhD, M Marwijk Kooy, MD, PhD, Petra Muus, MD, PhD, Gert J. Ossenkoppele, MD PhD, Joop H. Jansen, PhD, Arjan A. van de Loosdrecht, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1521.
https://doi.org/10.1182/blood.V122.21.1521.1521
Published: 2013
Journal Articles

Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,

Geert A Huls, Lieke H. van der Helm, Canan Alhan, P.W. Wijermans, MD, PhD, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Bart J Biemond, MD, Aart Beeker, Mels Hoogendoorn, Bastiaan P. van Rees, Okke de Weerdt, Jurgen Wegman, Eduard J Libourel, Sylvia A. Luykx-de Bakker, Monique C. Minnema, MD PhD, Rolf Brouwer, Fransien Croon-de Boer, Matthias Eefting, Kon-Siong G. Jie, Arjan A. van der Loosdrecht, Jan Koedam, Nic J.G.M. Veeger, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 3841.
https://doi.org/10.1182/blood.V118.21.3841.3841
Published: 2011
Journal Articles

Achievement of Complete Response Is a Strong Prognostic Factor In Elderly Newly Diagnosed Myeloma: Retrospective Analysis of 1175 Patients

Francesca Gay, Alessandra Larocca, P.W. Wijermans, Sara Bringhen, Tommasina Guglielmelli, Martijn R. Schaafsma, Giulia Benevolo, Vincenzo Callea, Luca Baldini, Fortunato Morabito, Mariella Grasso, Giuseppe Torelli, Manuela Rizzo, Monica Galli, Grazia Sanpaolo, Clotilde Cangialosi, Paola Omedè, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 1949.
https://doi.org/10.1182/blood.V116.21.1949.1949
Published: 2010
Journal Articles

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

Jan J. Cornelissen, Bronno van der Holt, Gregor E. G. Verhoef, Mars B. van 't Veer, Marinus H. J. van Oers, Harry C. Schouten, Gert Ossenkoppele, Pieter Sonneveld, Johan Maertens, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Pierre W. Wijermans, Douwe H. Biesma, Shulamit Wittebol, Paul J. Voogt, Joke W. Baars, Pierre Zachée, Leo F. Verdonck, Bob Löwenberg, Adriaan W. Dekker
Journal: Blood
Blood (2009) 113 (6): 1375–1382.
https://doi.org/10.1182/blood-2008-07-168625
Published: 2009
Includes: Supplemental data
Journal Articles

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Clinical Trials & Observations
Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt, Edo Vellenga, Alexandra J. Croockewit, Gregor E. G. Verhoef, Jan J. Cornelissen, Martijn R. Schaafsma, Marinus H. J. van Oers, Pierre W. Wijermans, Wim E. Fibbe, Shulamit Wittebol, Harry C. Schouten, Marinus van Marwijk Kooy, Douwe H. Biesma, Joke W. Baars, Rosalyn Slater, Monique M. C. Steijaert, Ivon Buijt, Henk M. Lokhorst
Journal: Blood
Blood (2003) 101 (6): 2144–2151.
https://doi.org/10.1182/blood-2002-03-0889
Published: 2003